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Abstract
Background: We have demonstrated that moderate alcohol consumption (15 g/d, 30 g/d) for 8 weeks resulted
in significantly increased levels of serum estrone sulfate and DHEAS in 51 postmenopausal women in a
randomized, placebo-controlled trial. We now report on the relationships between serum estrone sulfate and
dehydroepiandrosterone sulfate (DHEAS) levels after 4 weeks of moderate alcohol supplementation, and
compare the results to the 8 weeks data to elucidate time-to-effect differences.
Methods: Postmenopausal women (n = 51) consumed 0 (placebo), 15 (1 drink), and 30 (2 drinks) g alcohol
(ethanol)/ day for 8 weeks as part of a controlled diet in a randomized crossover design. Blood samples were
drawn at baseline, at 4 weeks and at 8 weeks. Changes in estrone sulfate and DHEAS levels from placebo to 15
g and 30 g alcohol per day were estimated using linear mixed models.
Results and Discussion: At week 4, compared to the placebo, estrone sulfate increased an average 6.9% (P =
0.24) when the women consumed 15 g of alcohol per day, and 22.2% (P = 0.0006) when they consumed 30 g
alcohol per day. DHEAS concentrations also increased significantly by an average of 8.0% (P < 0.0001) on 15 g of
alcohol per day and 9.2% (P < 0.0001) when 30 g alcohol was consumed per day. Trend tests across doses for
both estrone sulfate (P = 0.0006) and DHEAS (P < 0.0001) were significant. We found no significant differences
between the absolute levels of serum estrone sulfate at week 4 versus week 8 (P = 0.32) across all doses.
However, absolute DHEAS levels increased from week 4 to week 8 (P < 0.0001) at all three dose levels.
Conclusions: These data indicate that the hormonal effects due to moderate alcohol consumption are seen
early, within 4 weeks of initiation of ingestion.
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Background
Epidemiological evidence consistently shows a positive
association between alcohol, even low to moderate
intake, and breast cancer risk [1]. However, during the
past two decades, it has become evident that moderate
drinking is associated with longer life [2], reduced rates of
heart disease [3] and stroke [4]. What does this mean for
women when the epidemiologic data show an exposure is
associated with both benefits and harms? Recommenda-
tions regarding the use or avoidance of moderate alcohol,
must take into consideration both its potential benefit on
cardiovascular disease, as well as its potential risk for
breast cancer. To understand the biologic parameters
potentially influenced by alcohol, there is a need for well-
controlled mechanistic studies of dose and duration of
use on markers of risk in the causal pathway of breast
cancer.
A reanalysis of nine prospective studies shows that levels
of endogenous sex hormones are strongly associated with
breast cancer risk in postmenopausal women [5]. Clear
evidence that moderate alcohol consumption increases
levels of hormones associated with increased risk for
breast cancer would provide support for a causal relation-
ship. In a controlled study of acute alcohol ingestion,
serum estrone levels were significantly elevated in post-
menopausal women on hormone replacement therapy
(HRT), but did not affect serum estrone levels in women
not using HRT [6]. To better understand the effects of
moderate long-term alcohol ingestion on sex hormones,
we conducted a controlled feeding study in postmenopau-
sal women not using HRT. As previously reported, there
were significant elevations in both serum estrogen sulfate
and dehydroepiandrosterone sulfate (DHEAS) after 8
weeks of supplementation [7]. Here, we evaluate the rela-
tionships between serum estrogen sulfate and DHEAS
after 4 weeks of supplementation with moderate alcohol,
and compare the results to the 8 week data to elucidate
time-to-effect differences.
Methods
Details of the Women's Alcohol Study (WAS) was previ-
ously published [7]. Briefly, a total of 51 postmenopausal
women not on HRT completed the study and are included
in the analysis. The WAS utilized a crossover design. Each
participant rotated through three 8-weeks controlled die-
tary periods during which she consumed a beverage daily
that contained no alcohol (placebo), 15 g alcohol, or 30 g
alcohol in random order. Each of the three dietary periods
was preceded by a 2- to 5-week washout period during
which the women consumed no alcohol. Alcohol was
supplied as 95% ethanol (Everclear™ Pharmaco Products,
Inc., Brookfield, CN) in orange juice (12 ounces). All
meals were prepared at the Beltsville Human Nutrition
Research Center and the participants ate breakfast and
supper at the Center and had carryout lunches on week-
days. On weekends, food and beverages were packaged for
consumption at home. The calorie level for each subject
was adjusted to maintain constant body weight.
Blood for hormone analyses was collected after an over-
night fast at weeks 4 and 8. Serum was separated, and aliq-
uots were frozen at -70°C. In the samples taken after 4
weeks of alcohol supplementation, we only measured
serum estrone sulfate and DHEAS, as they were the only
two hormones that were significantly elevated at 8 weeks
[7].
Hormone concentrations were transformed using natural
log. Changes in hormone concentrations from placebo to
15 g and 30 g of alcohol per day were estimated at 4 and
8 weeks using linear mixed models including a random
intercept and alcohol levels as fixed effects treated as two
indicator variables. Separate models used alcohol as a
continuous variable to test for trend. Regressions to eval-
uate the effect of several baseline covariates on the preci-
sion of the parameter estimates for alcohol consumption
included age, BMI, and years since menopause modeled
as continuous fixed effects; assignment order, dietary
period, hysterectomy, and race were modeled as indicator
variables. Effect modification by race, assignment order,
dietary period, age, BMI, and years since menopause were
assessed by likelihood ratio tests of improvement in the
model fit after addition of cross-product terms to models
that included main effects for alcohol and the characteris-
tic being evaluated. All tests of statistical significance were
two-sided. Statistical analyses were performed using S-
PLUS (S-PLUS version 6.1 for Windows. Seattle (WA):
Insightful Corporation; 2002.)
Results and Discussions
Table 1 summarizes the mean hormone concentrations at
four weeks and eight weeks in the participants when not
consuming alcohol and the percent changes from no alco-
hol consumption when consuming 15 g or 30 g of alcohol
per day, respectively. At 4 weeks of alcohol intake the
inclusion of age, years since menopause, race, and base-
line BMI in the models did not change the precision of
parameter estimates for alcohol doses and thus results
from simple models are presented. At week 4, compared
to the no alcohol placebo, estrone sulfate increased an
average 6.9% (P = 0.24) when women consumed 15 g of
alcohol per day and 22.2% (P = 0.0006) when they con-
sumed 30 g of alcohol per day. DHEAS concentrations
also increased significantly by an average 8.0% (P <
0.0001) on 15 g of alcohol per day and 9.2% (P < 0.0001)
when 30 g alcohol was consumed per day at week 4. Trend
tests for both estrone sulfate (P = 0.0006) and DHEAS (P
< 0.0001) were highly significant.Nutrition Journal 2004, 3:11 http://www.nutritionj.com/content/3/1/11
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The effects of alcohol supplementation on serum estrone
sulfate and DHEAS levels did not vary with age, BMI, race,
or years since menopause. These hormone concentrations
also did not differ among the three dietary periods, and
the order of the assignment to the treatment regimens did
not modify the associations with either of the two
hormones.
At 8 weeks of alcohol intake, the 15 g dose versus the pla-
cebo increased serum estrone sulfate and DHEAS by 7.5%
and 5.1% respectively, whereas the 30 g dose compared to
the placebo, increased levels of estrone sulfate and
DHEAS by 10.7% and 7.5% respectively. When compari-
sons using linear mixed models are made, after control-
ling for alcohol intake across all doses, there was no
statistically significant difference between the absolute
levels of serum estrone sulfate at week 4 versus 8 (P =
0.32). However, controlling for alcohol intake absolute
DHEAS levels increased between weeks 4 and 8 (P <
0.0001). The increase in DHEAS between weeks 4 and 8
did not occur in just the 15 or 30 g per day groups, how-
ever; the increase was similar in each of the three groups.
In the 0 g per day group the geometric mean shifted from
55.3 ng/dL at 4 weeks to 59.4 ng/dL at 8 weeks. In the 15
g per day group the geometric mean shifted from 59.7 ng/
dL to 62.5 ng/dL, and in the 30 g per day group the geo-
metric mean shifted from 60.4 ng/dL to 63.9 ng/dL. The
models did not suggest an interaction between measure-
ment week and alcohol dose in serum estrone sulfate (P =
0.32) or DHEAS (P = 0.58).
In postmenopausal women moderate alcohol consump-
tion for four weeks resulted in statistically significant
increased levels of serum estrone sulfate, the most abun-
dant circulating estrogen, and DHEAS, the steroid hor-
mone with the highest concentration in the blood.
Compared to the placebo, serum estrone sulfate levels
increased 6.9% (P = 0.24) and 22.2% (P = 0.0006) respec-
tively among women who consumed 15 g and 30 g alco-
hol per day for four weeks. Serum DHEAS concentrations
also increased by 8.0% (P < 0.0001) and 9.2% (P <
0.0001) respectively among women who consumed 15 g
or 30 g alcohol per day for four weeks. At week 8, serum
estrone sulfate levels increased 7.5% and 10.7% respec-
tively among women who consumed 15 g and 30 g alco-
hol per day whereas DHEAS concentrations increased
5.1% and 7.5% respectively among women who con-
sumed 15 g or 30 g alcohol per day compared to the pla-
cebo [7]. The increased levels of serum estrone sulfate
concentrations at week 4 were essentially the same as
those seen at week 8. The % change in serum estrone sul-
fate levels from week 4 to week 8 is -0.1%, 0.5%, and -
8.9% respectively in the 0 g, 15 g, and 30 g alcohol doses.
Estrone sulfate does not show a consistent change over
time across all alcohol doses and there is no statistical evi-
dence of an interaction between time and alcohol (P =
0.32). Although there appears to be a difference when
looking at the point estimates in the 30 g alcohol dose,
variance in estrone sulfate is so large at both 4 weeks and
8 weeks the difference between the two point estimates is
not statistically significant. The large variance in estrogen
sulfate at the 30 g dose will require more people to accu-
rately judge this possible interaction.
For DHEAS, the absolute levels were statistically (P <
0.0001) higher at week 8 compared to week 4 in all the
alcohol groups. This increase in DHEAS between weeks 4
and 8 did not differ regardless of 0 g, 15 g, or 30 g per day
dose (P = 0.58). Biological reasons may explain the
increase in the 15 g and 30 g per day alcohol dose, but the
reasons behind the increases in DHEAS for the 0 g dose
need further research. We did not find any evidence for an
effect modification between measurement week and alco-
hol supplementation in serum estrone sulfate (P = 0.32)
or DHEAS (P = 0.58).
These data indicate that the hormonal effects due to mod-
erate consumption of alcohol equivalent to one or two
drinks per day are seen early, within 4 weeks of initiation
of ingestion. Importantly from a study design perspective,
Table 1: Geometric mean hormone levels (ng/dL) for participants on 0 g alcohol and % change (∆) in hormone levels from 0 g to 15 g 
and 30 g alcohol per day at weeks 4 and 8
Hormone 0 g/d, mean (95% C.I.) 15 g/d, ∆ (95% C.I.)* 30 g/d, ∆ (95% C.I.)* P-trend†
Estrone Sulfate (4 wk) 47.5 (39.2–57.4) 6.9% (-4.2%–19.3%) 22.2% (9.4%–36.5%) 0.0006
(8 wk) 47.4 (40.5–55.6) 7.5% (-0.3%–15.9%) 10.7% (2.7%–19.3%) 0.009
DHEAS (4 wk) 55.3 (47.0–65.1) 8.0% (4.5%–11.6%) 9.2% (5.6%–12.8%) <0.0001
(8 wk) 59.4 (50.5–70.0) 5.1% (1.4%–9.0%) 7.5% (3.7%–11.5%) 0.0001
* Estimates of percent change are from linear mixed models, including participant as a random effect and alcohol levels as fixed effects treated as 
two indicator variables.
† P-trend values (two-sided) are from linear mixed models, including participant as a random effect and alcohol levels as a continuous fixed effect 
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our study also demonstrates that it may be possible to uti-
lize shorter study periods when assessing the effects of
alcohol consumption on hormone levels, at least in post-
menopausal women. To understand the earliest effects of
moderate alcohol intake on hormone levels in postmeno-
pausal women, future studies will have to be designed to
assess serum levels earlier than 4 weeks or possibly later
than 8 weeks.
Postmenopausal women with elevated levels of serum
estrone sulfate [8,9] and DHEAS [8-11] levels were
reported to be at an increased risk of breast cancer in sev-
eral prospective cohort studies. Results from our study
showing statistically significant increased serum estrone
sulfate and DHEAS concentrations after four weeks of sup-
plementation with alcohol equivalent to one or two
drinks per day, provide one possible mechanism by which
moderate alcohol ingestion could increase breast cancer
risk in postmenopausal women.
Alcohol has many physiologic effects and could influence
breast cancer risk through non-hormonal mechanisms as
well. Experimental evidence suggests that alcohol inter-
feres with folate absorption, transport, and metabolism,
potentially limiting folate stores in the tissues and may
interfere with DNA methylation [12,13]. Alcohol con-
sumption and metabolism can result in increased produc-
tion of several classes of DNA damaging molecules
including reactive oxygen species [14] which can lead to
increase DNA damage and the development of breast can-
cer [15].
Conclusions
In conclusion, our results provide additional evidence for
a mechanism by which moderate alcohol drinking could
modify breast cancer risk, indicating that this effect occurs
after a short time period (as early as four weeks), and thus
provides further support for a causal association.
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